Clinical Impact of the Bronchiectasis with Chronic Bronchitis Symptoms in COPD: Analysis of a Longitudinal Cohort

References

• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• From the global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD); 2021. Available from: http://goldcopd.org. Accessed October 19, 2021.
   Google Scholar
• Martinez-Garcia MA, de la Rosa Carrillo D, Soler-Cataluna JJ, et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(8):823–831. doi:10.1164/rccm.201208-1518OC
   PubMed Web of Science ®Google Scholar
• Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(4):400–407. doi:10.1164/rccm.200305-648OC
   PubMed Web of Science ®Google Scholar
• Du Q, Jin J, Liu X, Sun Y. Bronchiectasis as a comorbidity of chronic obstructive pulmonary disease: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0150532. doi:10.1371/journal.pone.0150532
   PubMed Web of Science ®Google Scholar
• Gatheral T, Kumar N, Sansom B, et al. COPD-related bronchiectasis; independent impact on disease course and outcomes. COPD. 2014;11(6):605–614. doi:10.3109/15412555.2014.922174
   PubMedGoogle Scholar
• Martinez-Garcia MA, Soler-Cataluna JJ, Donat Sanz Y, et al. Factors associated with bronchiectasis in patients with COPD. Chest. 2011;140(5):1130–1137. doi:10.1378/chest.10-1758
   PubMed Web of Science ®Google Scholar
• Tulek B, Kivrak AS, Ozbek S, Kanat F, Suerdem M. Phenotyping of chronic obstructive pulmonary disease using the modified Bhalla scoring system for high-resolution computed tomography. Can Respir J. 2013;20:91–96.
   PubMed Web of Science ®Google Scholar
• Mao B, Lu H-W, Li M-H, et al. The existence of bronchiectasis predicts worse prognosis in patients with COPD. Sci Rep. 2015;5(1):1–9. doi:10.1038/srep10961
   Web of Science ®Google Scholar
• Bafadhel M, Umar I, Gupta S, et al. The role of CT scanning in multidimensional phenotyping of COPD. Chest. 2011;140(3):634–642. doi:10.1378/chest.10-3007
   PubMed Web of Science ®Google Scholar
• Jairam PM, van der Graaf Y, Lammers JW, Mali WP, de Jong PA. Incidental findings on chest CT imaging are associated with increased COPD exacerbations and mortality. Thorax. 2015;70(8):725–731. doi:10.1136/thoraxjnl-2014-206160
   PubMed Web of Science ®Google Scholar
• de Oca MM, Halbert RJ, Lopez MV, et al. The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study. Eur Respir J. 2012;40(1):28–36. doi:10.1183/09031936.00141611
   PubMed Web of Science ®Google Scholar
• Kim V, Zhao H, Boriek AM, et al. Persistent and newly developed chronic bronchitis are associated with worse outcomes in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2016;13(7):1016–1025. doi:10.1513/AnnalsATS.201512-800OC
   PubMed Web of Science ®Google Scholar
• Kim V, Sternberg AL, Washko G, et al. Severe chronic bronchitis in advanced emphysema increases mortality and hospitalizations. COPD. 2013;10(6):667–678. doi:10.3109/15412555.2013.827166
   PubMedGoogle Scholar
• Sherman CB, Xu X, Speizer FE, Ferris BG Jr, Weiss ST, Dockery DW. Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis. 1992;146:855–859. doi:10.1164/ajrccm/146.4.855
   PubMed Web of Science ®Google Scholar
• Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 1996;153(5):1530–1535. doi:10.1164/ajrccm.153.5.8630597
   PubMed Web of Science ®Google Scholar
• James A, Wenzel S. Clinical relevance of airway remodelling in airway diseases. Eur Respir J. 2007;30(1):134–155. doi:10.1183/09031936.00146905
   PubMed Web of Science ®Google Scholar
• Pelkonen M, Notkola I-L, Nissinen A, Tukiainen H, Koskela H. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest. 2006;130(4):1129–1137. doi:10.1378/chest.130.4.1129
   PubMed Web of Science ®Google Scholar
• Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax. 2009;64(10):894–900. doi:10.1136/thx.2008.110619
   PubMed Web of Science ®Google Scholar
• Kim V, Han MK, Vance GB, et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest. 2011;140(3):626–633. doi:10.1378/chest.10-2948
   PubMed Web of Science ®Google Scholar
• Lindberg A, Eriksson B, Larsson L-G, Rönmark E, Sandström T, Lundbäck B. Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest. 2006;129(4):879–885. doi:10.1378/chest.129.4.879
   PubMed Web of Science ®Google Scholar
• De Marco R, Accordini S, Cerveri I, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med. 2007;175(1):32–39. doi:10.1164/rccm.200603-381OC
   PubMed Web of Science ®Google Scholar
• Aliberti S, Lonni S, Dore S, et al. Clinical phenotypes in adult patients with bronchiectasis. Eur Respir J. 2016;47(4):1113–1122. doi:10.1183/13993003.01899-2015
   PubMed Web of Science ®Google Scholar
• Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580–586. doi:10.1378/chest.93.3.580
   PubMed Web of Science ®Google Scholar
• Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. Am Rev Respir Dis. 1992;145(6):1321–1327. doi:10.1164/ajrccm/145.6.1321
   PubMed Web of Science ®Google Scholar
• Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(3):1107–1136.
   PubMed Web of Science ®Google Scholar
• Lee YK, Oh YM, Lee JH, et al. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung. 2008;186(3):157–165. doi:10.1007/s00408-008-9071-0
   PubMed Web of Science ®Google Scholar
• Naidich DP, McCauley DI, Khouri NF, Stitik FP, Siegelman SS. Computed tomography of bronchiectasis. J Comput Assist Tomogr. 1982;6(3):437–444. doi:10.1097/00004728-198206000-00001
   PubMed Web of Science ®Google Scholar
• Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: scoring system with thin-section CT. Radiology. 1991;179(3):783–788. doi:10.1148/radiology.179.3.2027992
   PubMed Web of Science ®Google Scholar
• Kim V, Crapo J, Zhao H, et al. Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene. Ann Am Thorac Soc. 2015;12(3):332–339. doi:10.1513/AnnalsATS.201411-518OC
   PubMed Web of Science ®Google Scholar
• Lim JU, Lee J-H, Kim T-H, et al. Alternative definitions of chronic bronchitis and their correlation with CT parameters. Int J Chron Obstruct Pulmon Dis. 2018;13:1893. doi:10.2147/COPD.S164055
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. doi:10.1016/S0140-6736(07)61382-8
   PubMed Web of Science ®Google Scholar
• Kim J, Yoon HI, Oh YM, et al. Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1819–1827. doi:10.2147/COPD.S87766
   PubMed Web of Science ®Google Scholar
• Metersky ML. The initial evaluation of adults with bronchiectasis. Clin Chest Med. 2012;33(2):219–231. doi:10.1016/j.ccm.2012.03.004
   PubMed Web of Science ®Google Scholar
• Perry KM, King DS. Bronchiectasis: a study of prognosis based on a follow-up of 400 patients. Am Rev Tuberc. 1940;41(5):531–548.
   Google Scholar
• O’Brien C, Guest P, Hill S, Stockley R. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax. 2000;55(8):635–642. doi:10.1136/thorax.55.8.635
   PubMed Web of Science ®Google Scholar
• Dakin CJ, Pereira JK, Henry RL, Wang H, Morton JR. Relationship between sputum inflammatory markers, lung function, and lung pathology on high-resolution computed tomography in children with cystic fibrosis. Pediatr Pulmonol. 2002;33(6):475–482. doi:10.1002/ppul.10109
   PubMed Web of Science ®Google Scholar
• Finch S, McDonnell MJ, Abo-Leyah H, Aliberti S, Chalmers JD. A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc. 2015;12(11):1602–1611.
   PubMed Web of Science ®Google Scholar
• Martínez-García MÁ, De Gracia J, Relat MV, et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J. 2014;43(5):1357–1367. doi:10.1183/09031936.00026313
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index: an international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576–585. doi:10.1164/rccm.201309-1575OC
   PubMed Web of Science ®Google Scholar
• Desai H, Eschberger K, Wrona C, et al. Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(3):303–309. doi:10.1513/AnnalsATS.201310-350OC
   PubMedGoogle Scholar
• Kwok WC, Ho JCM, Tam TCC, Ip MSM, Lam DCL. Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications. Respir Res. 2021;22(1):132. doi:10.1186/s12931-021-01729-5
   PubMed Web of Science ®Google Scholar
• Banerjee D, Khair O, Honeybourne D. Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD. Eur Respir J. 2004;23(5):685–691. doi:10.1183/09031936.04.00056804
   PubMed Web of Science ®Google Scholar
• Ferris B. Epidemiology standardization project (American Thoracic Society): recommended respiratory disease questionnaires for use with adult and children in epidemiological research. Am Rev Respir Dis. 1978;118:7–53.
   PubMed Web of Science ®Google Scholar
• Kim V, Zhao H, Regan E, et al. The St. George’s Respiratory Questionnaire definition of chronic bronchitis may be a better predictor of COPD exacerbations compared with the classic definition. Chest. 2019;156(4):685–695. doi:10.1016/j.chest.2019.03.041
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662–671. doi:10.1164/rccm.201104-0597OC
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2012;186(1):48–55. doi:10.1164/rccm.201108-1553OC
   PubMed Web of Science ®Google Scholar